Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
141
-
Total 13F shares, excl. options
-
26,760,101
-
Shares change
-
-4,113,769
-
Total reported value, excl. options
-
$112,930,774
-
Value change
-
-$18,727,572
-
Put/Call ratio
-
113%
-
Number of buys
-
59
-
Number of sells
-
-66
-
Price
-
$4.22
Significant Holders of ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) as of Q2 2024
174 filings reported holding AVXL - ANAVEX LIFE SCIENCES CORP. - COM NEW as of Q2 2024.
ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) has 141 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,760,101 shares
.
Largest 10 shareholders include BlackRock Inc. (6,391,472 shares), VANGUARD GROUP INC (4,548,219 shares), STATE STREET CORP (3,740,356 shares), GEODE CAPITAL MANAGEMENT, LLC (1,831,253 shares), TWO SIGMA INVESTMENTS, LP (1,012,883 shares), NORTHERN TRUST CORP (669,156 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (651,084 shares), TWO SIGMA ADVISERS, LP (633,000 shares), BANK OF AMERICA CORP /DE/ (600,359 shares), and RENAISSANCE TECHNOLOGIES LLC (466,437 shares).
This table shows the top 141 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.